F Jia, X Liu, L Li, SK Mallapragada, B Narasimhan, and Q Wang, “Multifunctional nanoparticles for targeted delivery of anti-cancer therapeutics and immune activation,” J Contr Rel, 172, 1020-1034 (2013)
Y Phanse, BR Carrillo-Conde, AE Ramer-Tait, R Roychoudhury, NLB Pohl, MJ Wannemuehler, B Narasimhan, and BH Bellaire, “Functionalization of polyanhydride microparticles by di-mannose influences their uptake by and intracellular fate within dendritic cells,” Acta Biomater, 9(11), 8902-8909 (2013)
SL Haughney, LK Petersen, AE Ramer-Tait, J King, A Schoofs, D Briles, MJ Wannemuehler, and B Narasimhan, “Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles,” Acta Biomater, 9(9), 8262-8271 (2013)
LK Petersen, L Huntimer, KA Walz, AE Ramer-Tait, MJ Wannemuehler, and B Narasimhan, “Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platform for vaccine delivery,” Int J Nanomed, 8, 2213-2225 (2013)
VB Joshi, SM Geary, BR Carrillo-Conde, B Narasimhan, and AK Salem, “Characterizing the anti-tumor response in mice treated with antigen-loaded polyanhydride microparticles,” Acta Biomater, 9(3), 5583-5589 (2013)
F Jia, B Narasimhan, and SK Mallapragada, “Biomimetic multi-enzyme complexes based on nanoscale platforms,” AIChE J, 59(2), 355-360 (2013)
LM Huntimer, JH Wilson-Welder, KA Ross, B Carrillo-Conde, L Pruisner, C Wang, B Narasimhan, MJ Wannemuehler, and AE Ramer-Tait, “Single immunization of a suboptimal dose of antigen encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses,” J Biomed Mater Res B, 101B, 91-98 (2013)
LM Huntimer, AE Ramer-Tait, LK Petersen, KA Ross, KA Walz, C Wang, JM Hostetter, B Narasimhan, and MJ Wannemuehler, “Evaluation of biocompatibility and administration site reactogenicity of polyanhydride particle-based platform for vaccine delivery,” Adv Healthcare Mater, 2, 369-378 (2013)
R Roychoudhury, JE Vela-Ramirez, B Narasimhan, and NLB Pohl, “Application of a fluorous amine-protecting group in the automated synthesis of oligomannosides for the development of three-component anti-HIV-1 vaccines,” Abstracts Papers ACS, 246, 66 (2013)
R Darling, LM Huntimer, KA Ross, AE Ramer-Tait, B Narasimhan, and MJ Wannemuehler, “Polyanhydride nanoparticle vaccine platform delays tumor growth,” J Immunol, 190, P2050 (2013)
LM Huntimer, KA Ross, R Darling, AE Ramer-Tait, B Narasimhan, and MJ Wannemuehler, “Humoral immune responses elicited by the polyanhydride particle vaccine platform are facilitated by enhanced T follicular helper cell phenotype,” J Immunol, 190, P4366 (2013)
LM Huntimer, KA Ross, AE Ramer-Tait, B Narasimhan, and MJ Wannemuehler, “Polyanhydride particle vaccine platform enhances early antigen-specific cytotoxic T cell responses,” J Immunol, 190, 17918 (2013)
Y Phanse, P Lueth, AE Ramer-Tait, BR Carrillo-Conde, B Narasimhan, MJ Wannemuehler, and BH Bellaire, “Evaluating cellular interactions of polyanhydride particles for intracellular delivery of antibiotics”, Trans Soc Biomater, 36, 378 (2013)
Y Phanse, LK Petersen, SL Haughney, AE Ramer-Tait, JM Hostetter, B Narasimhan, and MJ Wannemuehler, “Single dose polyanhydride nanoparticle-based vaccine safely induces both cellular and humoral immunity”, Trans Soc Biomater, 36, 356 (2013)
R Darling, L Huntimer, KA Ross, N Winterwood, B Narasimhan, AE Ramer-Tait, and MJ Wannemuehler, “Polyanhydride nanoparticle vaccine platform delays tumor growth in an antigen specific model”, Trans Soc Biomater, 36 (2013)
Y Phanse, P Lueth, J Groen, J Ritchie, BR Carrillo-Conde, LK Petersen, P Imerman, B Narasimhan, and BH Bellaire, “Nanoparticle-based platform enables increased intracellular antibiotic delivery and killing of Brucella”, Trans Soc Biomater, 36 (2013)
J Vela-Ramirez, R Roychoudhury, H Habte, M Cho, NL Pohl, MJ Wannemuehler, and B Narasimhan, “Functionalized polyanhydride nanoparticles preserve protein stability and activate antigen presenting cells”, Trans Soc Biomater, 36 (2013)
L Huntimer, AE Ramer-Tait, LK Petersen, KA Ross, KA Walz, C Wang, JM Hostetter, MJ Wannemuehler, and B Narasimhan, “Polyanhydride nanoparticle-based influenza vaccine elicits viral neutralizing titers and enhances cell-mediated immunity”, Trans Soc Biomater, 36 (2013)
KA Ross, SL Haughney, TM Brenza, L Huntimer, P Boggiato, MJ Wannemuehler, and B Narasimhan, “Deposition and persistence of polyanhydride nanoparticle vaccines upon intranasal administration”, Trans Soc Biomater, 36 (2013)
L Huntimer, KA Ross, R Darling, AE Ramer-Tait, MJ Wannemuehler, and B Narasimhan, “Humoral responses elicited by polyanhydride nanoparticle formulations are facilitated by enhanced CD4+ T cell helper cells”, Trans Soc Biomater, 36 (2013)
L Huntimer, KA Ross, R Darling, AE Ramer-Tait, MJ Wannemuehler, and B Narasimhan, “Polyanhydride particle vaccine platform enhances antigen-specific cytotoxic T cell responses”, Trans Soc Biomater, 36 (2013)
TM Brenza, LK Petersen, Y Zhang, L Huntimer, AE Ramer-Tait, MJ Wannemuehler, and B Narasimhan, “Biodistribution and trafficking of intranasally administered monodisperse biodegradable particles,” J Aerosol Med Pulmon Drug Del, 26(2), A30 (2013)
F Jia, SK Mallapragada, and B Narasimhan, “DNA directed multi-enzyme co-localization on nanoparticles,” Abstracts Papers ACS, 245, 752 (2013)